Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
1.570
-0.110 (-6.55%)
At close: Nov 20, 2026, 4:00 PM EST
1.500
-0.070 (-4.46%)
After-hours: Nov 20, 2026, 6:48 PM EST
Niki BioSolutions Employees
Niki BioSolutions had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Niki BioSolutions the 44,068th largest employer in the world and 7,236th in the United States.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,247,494
Market Cap
4.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Cerenome | 28 |
| Curis | 24 |
| Cardio Diagnostics Holdings | 17 |
| VivoSim Labs | 15 |
| Kiora Pharmaceuticals | 13 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
NIKI News
- 11 days ago - Niki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2026 Conference - GlobeNewsWire
- 26 days ago - Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine - GlobeNewsWire
- 4 weeks ago - Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research - GlobeNewsWire
- 5 weeks ago - Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series - GlobeNewsWire
- 5 weeks ago - Niki BioSolutions Partners with Global Alzheimer's Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002 - GlobeNewsWire
- 1 month ago - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 2 months ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 2 months ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire